Canoe Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$139M Buy
364,526
+1,022
+0.3% +$408K 1.67% 25
2026
Q2
$141M Sell
363,504
-3,783
-1% -$1.4M 1.74% 25
2026
Q1
$108M Sell
367,287
-3,375
-0.9% -$1.11M 1.47% 31
2025
Q4
$130M Sell
370,662
-18,737
-5% -$6.33M 1.76% 23
2025
Q3
$126M Buy
389,399
+59,743
+18% +$18.6M 1.8% 24
2025
Q2
$128M Buy
329,656
+6,018
+2% +$2.42M 1.83% 21
2025
Q1
$141M Sell
323,638
-200,893
-38% -$80.6M 2.26% 17
2024
Q4
$193M Buy
524,531
+182,807
+53% +$76.5M 3.15% 9
2024
Q3
$179M Buy
341,724
+9,024
+3% +$4.82M 4.3% 3
2024
Q2
$173M Hold
332,700
– – 3.2% 8
2024
Q1
$173M Sell
332,700
-3,422
-1% -$1.7M 2.84% 9
2023
Q4
$159M Buy
336,122
+9,116
+3% +$4.22M 3.11% 5
2023
Q3
$193M Buy
327,006
+144,422
+79% +$65.5M 5.4% 2
2023
Q2
$81.2M Sell
182,584
-13,615
-7% -$6.28M 1.7% 21
2023
Q1
$90.2M Buy
+196,199
New +$93.4M 1.26% 28

Other funds holding ELV

Canoe Financial's ELV Position: Q3 2026 in Review

Canoe Financial increased its Elevance Health (ELV) stake by 0.28% in Q3 2026, buying an estimated $408K and bringing the position to 364,526 shares worth $139M. The position accounts for 1.67% of the portfolio, ranked #25.

Canoe Financial first reported a position in ELV in Q1 2023 and has held it in 15 quarters since. The position peaked at $193M in Q4 2024. 951 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Canoe Financial held 364,526 shares of Elevance Health worth $139M as of Q3 2026.
  • Canoe Financial bought 1,022 Elevance Health shares in Q3 2026, an estimated $408K.
  • Elevance Health made up 1.67% of Canoe Financial's portfolio in Q3 2026, its #25 holding.
  • Canoe Financial first reported a position in Elevance Health in Q1 2023 and has held it in 15 quarters since.
  • Canoe Financial's Elevance Health position peaked at $193M in Q4 2024.
  • 951 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Canoe Financial's 13F filing for Q3 2026, filed 21 Oct 2026.